Long-term effects of fecal microbiota transplant
Part of Digestive system, Mental health clinical trials.
This study looks at how well fecal microbiota transplantation (FMT) works over time and checks its safety. If you have received at least one FMT for a qualifying condition, you may be able to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with one of the target diseases (for example, certain gut or metabolic conditions).
- You are 3 years old or older.
- You have had at least one fecal microbiota transplant (FMT) treatment.
- Your doctor has complete health records from before and after your FMT.
- You or your guardian agree to be part of the study or allow your medical data to be used.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how fecal microbiota transplantation (FMT) affects the gut microbiome in people with ulcerative colitis, metabolic syndrome, or recurrent C. diff infection. It aims to understand how the donor bacteria settle in the gut.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This study looks at fecal microbiota transplantation (FMT), which is a stool bacteria transplant, to help adults whose symptoms persist or return, often from C. difficile infection. If you’re already planning or receiving FMT for certain conditions, this trial may add information on how it helps and who benefits.
This trial tests whether fecal microbiota transplantation (FMT) can safely and effectively treat mild to moderate ulcerative colitis over the long term. FMT involves transferring stool from a healthy donor to restore a healthy balance of gut bacteria.
This study creates a registry for people who receive fecal microbiota transplants (FMT) to track long-term safety and outcomes. It may help researchers understand how this treatment works over time.
This trial tests whether one or multiple fecal transplants from a healthy donor can help treat both a recurring C. diff infection and active ulcerative colitis. It aims to find the best schedule for the procedure.
Hear when a new Clostridium Difficile Infection Recurrence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.